乳腺癌、甲状腺癌的综合诊治与基础研究；

液态活检与70基因检测等精准医学研究；

乳腺疾病全程管理

Comprehensive diagnosis and treatment & basic research of breast and thyroid cancers;

precision medicine including liquid biopsy and 70-gene assay; whole-course management of breast diseases.

• 中国抗癌协会乳腺癌专业委员会 常委

• 中国医师协会外科医师分会乳腺外科专业委员会 常委

• 中华医学会肿瘤学分会乳腺癌学组 委员

• 中国医师协会临床精准医疗专业委员会乳腺癌学组 副主任委员

• 中国临床肿瘤学会（CSCO）乳腺癌专家委员会 委员

• 中国医药教育协会乳腺疾病专业委员会 常委

• 中国研究型医院学会乳腺专业委员会 常委

• 全军普通外科专业委员会内分泌乳腺学组 副组长

• 上海抗癌协会乳腺癌专业委员会 副主任委员

• 上海市医学会外科分会乳腺学组 副组长

• 上海市医学会普外科专科分会甲状腺外科学组 副组长

• Standing Committee Member, Breast Cancer Committee of China Anti-Cancer Association

• Standing Committee Member, Breast Surgery Committee of Chinese Medical Doctor Association

• Member, Breast Cancer Group of Oncology Branch of Chinese Medical Association

• Vice Chairman, Breast Cancer Group of Precision Medicine Committee of Chinese Medical Doctor Association

• Member, Breast Cancer Expert Committee of Chinese Society of Clinical Oncology (CSCO)

• Standing Committee Member, Breast Disease Committee of China Medical Education Association

• Standing Committee Member, Breast Professional Committee of Chinese Research Hospital Association

• Deputy Group Leader, Endocrine and Breast Group of the General Surgery Committee of the Whole Army

• Vice Chairman, Breast Cancer Committee of Shanghai Anti-Cancer Association

• Deputy Group Leader, Breast Group of the Surgery Branch of Shanghai Medical Association

• Deputy Group Leader, Thyroid Surgery Group of the General Surgery Branch of Shanghai Medical Association

1. 主持/参与国家级及省部级课题近20项，含国家“973”重大项目、国家自然科学基金、上海市自然科学基金等，基金总额超500万元。

2. 主编及参编医学专著7部；牵头制定《中国乳腺癌患者BRCA基因检测与临床应用专家共识》，纳入2019年中国抗癌协会乳腺癌专业委员会系列指南。

3. 发表学术论文近30篇，其中以第一/通讯作者发表SCI论文17篇（单篇最高IF=6.359，累计IF=56.8114），核心期刊论文6篇。

4. 主持多项全国多中心研究，包括Aphynity国际临床试验、70基因检测乳腺癌预后研究，成果发表于NEJM、JCO等权威期刊。

5. 获国家实用新型专利3项、军队医疗成果三等奖1项。

1. Presided over/participated in nearly 20 national and provincial-level projects, including the National 973 Program, NSFC, Shanghai Natural Science Foundation, with total funding over 5 million RMB.

2. Editor-in-chief/participating editor of 7 medical monographs; led the development of the Expert Consensus on BRCA Gene Testing and Clinical Application for Chinese Breast Cancer Patients, included in the 2019 CACA Breast Cancer Guidelines.

3. Published nearly 30 academic papers, including 17 SCI papers as first/corresponding author (highest IF=6.359, cumulative IF=56.8114) and 6 core journal papers.

4. Led multiple national multi-center studies, including the Aphynity international trial and the 70-gene assay breast cancer prognosis study, with results published in top journals like NEJM and JCO.

5. Awarded 3 national utility model patents and the Third Prize of Military Medical Achievements.